Travel6 days ago
Epcoritamab Is Associated With Higher Travel Burden/Costs in R/R DLBCL and Follicular Lymphoma
Findings from an analysis of real-world patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) or follicular lymphoma being treated with bispecific antibodies showed that epcoritamab-bysp (Epkinly)...
